TruDoc Healthcare, a virtual primary care provider in the Gulf Cooperation Council (GCC), has acquired the Asian chronic disease management platform Wellthy Therapeutics.
The companies have not disclosed financial terms and other details of the transaction.
Based in Mumbai, India, Wellthy Therapeutics provides solutions that combine behavioural science and technology to deliver personalised digital therapies.
Wellthy’s acquisition will support the expansion of Dubai-based company TruDoc into the Asian markets, including India.
The deal further integrates Wellthy Therapeutics' advanced behavioural science and digital therapeutic solutions with TruDoc's extensive virtual and in-home healthcare services.
This integration is expected to provide patients with 24/7 access to healthcare, tailored treatment plans, and innovative care delivery methods, potentially enhancing health results and streamlining healthcare expenditures.
According to Wellthy, the new alliance is set to reinforce TruDoc's position as a leading tech-enabled primary care provider in both GCC and Asian markets.
The TruDoc and Wellthy Therapeutics synergy will empower insurers, employers, and governments to offer individualised care.
Integrated services will provide connected care, remote monitoring, and instant access to healthcare professionals, all supported by AI and personalised care protocols.
This approach is projected to elevate patient care and deliver validated cost reductions across the outpatient spectrum.
Regarding the acquisition, TruDoc chairman Vish Narain said: “We envision a future where primary care is easily accessible, starting with digital platforms, followed by in-home care, with in-clinic visits only when needed.”
Wellthy highlighted that the latest acquisition is also in line with the shared Vision 2025 and will allow the companies to combine their clinical strengths and digital health expertise to benefit people and create a sustainable healthcare ecosystem.
This strategic partnership is also a significant move towards offering full-stack primary care, leveraging TruDoc's clinical proficiency and Wellthy Therapeutics' digital health and behavioural science capabilities.
Wellthy Therapeutics founder Abhishek Shah said: “The combined capabilities are uniquely positioned to significantly lower healthcare expenses, contribute to savings, and reduce unnecessary hospital and clinic visits while substantially improving the patient experience.”
